RECRUITING

Strategic Targeting for Optimal Prevention of Cancer

Description

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Study Overview

Study Details

Study overview

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Strategic Targeting for Optimal Prevention of Cancer

Strategic Targeting for Optimal Prevention of Cancer

Condition
Early Detection of Cancer
Intervention / Treatment

-

Contacts and Locations

Prosper

Sunbeam Clinical, Prosper, Texas, United States, 75078

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Study subjects may be included in the Clinical Trial if they meet all of the following
  • * Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
  • * study subject is unable to provide an accurate history due to mental incapacity
  • * study subject is currently abusing illicit and/or prescription drugs;

Ages Eligible for Study

65 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

ClinLogic LLC,

Study Record Dates

2025-08-01